Literature DB >> 7864114

Plasma arginine, citrulline, and ornithine kinetics in adults, with observations on nitric oxide synthesis.

L Castillo1, M Sánchez, J Vogt, T E Chapman, T C DeRojas-Walker, S R Tannenbaum, A M Ajami, V R Young.   

Abstract

The plasma fluxes of ornithine (Orn), arginine (Arg), and citrulline (Cit) and rate of conversion of labeled ornithine-to-citrulline (QOrn-->Cit) were estimated in six healthy adult men receiving an arginine-rich or arginine-free L-amino acid-based diet, each for 6 days. On day 7 an 8-h (3-h fast, 5-h fed) primed continuous intravenous infusion of L-[guanido-15N,15N] arginine, L-[ureido-13C]citrulline, L-[5,5,2H2]ornithine, and L-[5,5,5-2H3]leucine was conducted. Mean citrulline fluxes (mumol.kg-1.h-1) were 10.4-13.6 for the various conditions and/or diets and remained unchanged (P > 0.05). Arginine flux was lowered (P < 0.01) by 38% for fed state during arginine-free period. Ornithine fluxes for arginine-rich were (P < 0.01) reduced with the arginine-free diet. Rates of QOrn-->Cit declined by 30% (P < .05) during the fed arginine-free period. Short-term restriction in the dietary supply of arginine did not alter the rate of whole body nitric oxide synthesis. One subject showed a very high output of nitrate on arginine-free diet (6 times average for remaining subjects).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864114     DOI: 10.1152/ajpendo.1995.268.2.E360

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  In vivo measurement of nitric oxide production in porcine gut, liver and muscle during hyperdynamic endotoxaemia.

Authors:  Maaike J Bruins; Wouter H Lamers; Alfred J Meijer; Peter B Soeters; Nicolaas E P Deutz
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Whole body nitric oxide synthesis in healthy men determined from [15N] arginine-to-[15N]citrulline labeling.

Authors:  L Castillo; L Beaumier; A M Ajami; V R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 3.  Arginine de novo and nitric oxide production in disease states.

Authors:  Yvette C Luiking; Gabriella A M Ten Have; Robert R Wolfe; Nicolaas E P Deutz
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-25       Impact factor: 4.310

4.  De novo synthesis is the main source of ornithine for citrulline production in neonatal pigs.

Authors:  Juan C Marini; Barbara Stoll; Inka Cajo Didelija; Douglas G Burrin
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-16       Impact factor: 4.310

Review 5.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

Review 6.  Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline.

Authors:  Ludy Lutgens; Philippe Lambin
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

Review 7.  Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria.

Authors:  J Brice Weinberg; Bert K Lopansri; Esther Mwaikambo; Donald L Granger
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

8.  Arginine appearance and nitric oxide synthesis in critically ill infants can be increased with a protein-energy-enriched enteral formula.

Authors:  Carlijn T I de Betue; Koen F M Joosten; Nicolaas E P Deutz; Anita C E Vreugdenhil; Dick A van Waardenburg
Journal:  Am J Clin Nutr       Date:  2013-08-14       Impact factor: 7.045

9.  Intestinal and hepatic metabolism of glutamine and citrulline in humans.

Authors:  Marcel C G van de Poll; Gerdien C Ligthart-Melis; Petra G Boelens; Nicolaas E P Deutz; Paul A M van Leeuwen; Cornelis H C Dejong
Journal:  J Physiol       Date:  2007-03-08       Impact factor: 5.182

10.  Acute L-arginine alpha ketoglutarate supplementation fails to improve muscular performance in resistance trained and untrained men.

Authors:  Benjamin Wax; Andreas N Kavazis; Heather E Webb; Stanley P Brown
Journal:  J Int Soc Sports Nutr       Date:  2012-04-17       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.